Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Comment by Benedictuson Jan 30, 2024 12:39am
193 Views
Post# 35851959

RE:RE:RE:RE:RE:RE:RE:Does CG0070 have better efficacy than Ruvidar PDT?

RE:RE:RE:RE:RE:RE:RE:Does CG0070 have better efficacy than Ruvidar PDT?
Longholder99 wrote: I suggest that the people sitting at home with bladders intact, having not suffered the life altering effects of genetically forced medical mutation to their immune system courtesy of drugs like Keytruda.  May disagree with the term Mickey Mouse when referring to TLD1433 and the development of an effective ACT by Theralase.   Once this next hurdle of BTD is cleared I guess we shall see.  

You are mischaracterizing my post. To be clear, I view the science as having tremendous potential but it's been completely hamstrung by the  business side of the operation, which whether bulls want to admit it or not, currently has an exposed underbelly, closing a series of undersubscribed lower priced pp's, with shorts capping rallies, managing the sp incrementally lower and lower. Keeping the lights on with the funds to advance all indications is really the number one imperative of the executive team and yet the company limps along from one underwhelming pp to the next. 
<< Previous
Bullboard Posts
Next >>